All Search Results
-
Touch-a-Truck
Saturday, March 5, 2016
-
JDRF Walk Orlando
Saturday, March 5
-
Why Am I Coughing? It Could Be the Flu — or Vaping
The outbreak of vaping-related lung injuries shows no sign of decreasing across the United States and, with the onset of flu season, it would be very easy to confuse the two. The symptoms are very much the same.
-
Crohn's & Colitis Pediatric Education Day
The Crohn’s & Colitis Foundation of America and the Arnold Palmer Hospital for Children Center for Digestive Health and Nutrition invite
-
U.S. News & World Report Ranks Orlando Health Among the Best in the Nation
Orlando Health hospitals and service lines were recognized among the best in the nation and region in U.S. News & World Report’s adult hospital rankings, which were released today.
-
U.S. News & World Report Ranks Orlando Health Among Nation’s Best Pediatric Hospitals
For the 16th consecutive year, Orlando Health hospitals were recognized among the nation’s “Best Children's Hospitals" for 2025-2026 by U.S. News and World Report with the most Top-50 pediatric programs in Orlando.
-
Winnie Palmer Hospital Delivers 100,000th Baby
Hridaya Raj is the 100,000th baby born at Winnie Palmer Hospital.
-
Orlando Health Treats First Pediatric Patient using Proton Therapy
ORLANDO, FL. (May 26, 2016) – When Zayne Burton’s parents, Lori and Chaz, heard the diagnosis that their 12-year-old son had a medullablastoma, a tumor of the brain and spine, they were in shock. Quickly, however, their focus turned to treating the curable cancer so their son could go on to live a healthy life. Their journey brought them to The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center - Orlando Health, which had just opened, becoming the first proton center in Central Florida to treat patients us-ing proton beams, a type of radiation therapy, to shrink tumors. Just weeks after his diagnosis and surgery to remove the tumor, Zayne, a 7th grader from Orlando, began proton therapy treatment at UF Health Cancer Center - Orlando Health, becoming the first pediatric patient treated in Central Florida with this revolutionary treatment option.
-
Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma
-
Surveillance or Treatment of Patients w/Germ Cell Tumors
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
